Literature DB >> 24631090

Purification of O-specific polysaccharide from lipopolysaccharide produced by Salmonella enterica serovar Paratyphi A.

Sudeep Kothari1, Jeong-Ah Kim2, Neha Kothari2, Christopher Jones3, Woo Seok Choe4, Rodney Carbis5.   

Abstract

The O specific polysaccharide (OSP) of the lipopolysaccharide (LPS) of Salmonella enterica serovar Paratyphi A is a protective antigen and the target for vaccine development. LPS is the major constituent of the outer membrane of S. Paratyphi A with the OSP exposed on the surface, in addition to the cell associated LPS a large amount of free LPS was present in the fermentation broth. A purification method was developed to take advantage of both sources of LPS and to maximize recovery of OSP. After fermentation the bacterial cells were concentrated and washed, the permeate containing the free LPS was processed separately from the cells. The free LPS was concentrated and washed on a 100kD ultrafiltration membrane to remove low molecular weight impurities. The LPS was then detoxified by separation of the lipid A from the OSP using acid hydrolysis at 100°C, the precipitated lipid A was removed by 0.2μm membrane filtration. Contaminants were then removed by acid precipitation in the presence of sodium deoxycholate. The OSP was concentrated and washed with 1M NaCl then water using a 10kD ultrafiltration membrane then sterile filtered through a 0.2μm membrane filter. The cells were treated by acid hydrolysis at 100°C, the remaining cells, cell debris and precipitate was removed by centrifugation. The filtrate was then treated in the same way as described above for the free LPS. The combined yield of purified OSP from free LPS plus the cells was greater than 880mg/L of culture broth. The method developed yields large amounts of OSP, is scalable and compatible with cGMP so would be readily transferrable to developing country vaccine manufacturers for low cost production of vaccine against S. Paratyphi A.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Enteric fever vaccine; O-specific polysaccharide; Polysaccharide purification; Salmonella Paratyphi; Vaccine production

Mesh:

Substances:

Year:  2014        PMID: 24631090     DOI: 10.1016/j.vaccine.2014.02.090

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Isolation, Purification, Characterization and Direct Conjugation of the Lipid A-Free Lipopolysaccharide of Vibrio cholerae O139.

Authors:  Peng Xu; Jana Korcová; Peter Baráth; Alžbeta Čížová; Jana Valáriková; Firdausi Qadri; Meagan Kelly; Robert D O'Connor; Edward T Ryan; Slavomír Bystrický; Pavol Kováč
Journal:  Chemistry       Date:  2019-08-20       Impact factor: 5.236

2.  Attenuated Salmonella Typhimurium expressing Salmonella Paratyphoid A O-antigen induces protective immune responses against two Salmonella strains.

Authors:  Qing Liu; Pei Li; Hongyan Luo; Roy Curtiss; Qingke Kong
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

Review 3.  Vaccines against invasive Salmonella disease: current status and future directions.

Authors:  Calman A MacLennan; Laura B Martin; Francesca Micoli
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

4.  Purification and antigenic detection of O-specific polysaccharides of Salmonella enterica serovar Paratyphi A isolate from Pakistan: an emerging threat.

Authors:  Zainab Rahmat; Aamir Ali; Yasra Sarwar; Muhammad Salman; Abdul Haque
Journal:  Springerplus       Date:  2016-11-10

Review 5.  Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.

Authors:  Yi-An Yang; Alexander Chong; Jeongmin Song
Journal:  Vaccines (Basel)       Date:  2018-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.